Showing results (1-10 of 28) with videos related to
Sort By:
Pageof 3
Current Opinion in Pharmacology|August 7, 2003
JNK: a new therapeutic target for diabetesBrydon L Bennett, Yoshitaka Satoh, Alan J LewisTransplantation|May 24, 2007
Suppression of alloreactivity and allograft rejection by SP600125, a small molecule inhibitor of c-Jun N-terminal kinaseAkihiro Tabata, Masayuki Morikawa, Masahiro Miyajima, et al.International Journal of Molecular Medicine|February 9, 2006
Pro-inflammatory signaling by Jun-N-terminal kinase in inflammatory bowel diseaseKeiichi Mitsuyama, Asuka Suzuki, Nobuo Tomiyasu, et al.Clinical Immunology (Orlando, Fla.)|June 21, 2008
CC-4047 promotes Th1 cell differentiation and reprograms polarized human Th2 cells by enhancing transcription factor T-betWeiming Xu, Maria Celeridad, Sabita Sankar, et al.Regenerative Medicine|March 26, 2009
Working for a cure for Type 1 diabetes. An interviewAlan J LewisAmerican Journal of Physiology. Cell Physiology|June 11, 2002
Differential requirement for NF-kappaB-inducing kinase in the induction of NF-kappaB by IL-1beta, TNF-alpha, and FasMaria P Russo, Brydon L Bennett, Anthony M Manning, et al.Seminars in Oncology|April 30, 2003
Potential new therapeutics for Waldenstrom's macroglobulinemiaJerome B Zeldis, Peter H Schafer, Brydon L Bennett, et al.FASEB Journal : Official Publication of the Federation of American Societies for Experimental Biology|February 10, 2004
Differential requirement for c-Jun NH2-terminal kinase in TNFalpha- and Fas-mediated apoptosis in hepatocytesRobert F Schwabe, Hiroshi Uchinami, Ting Qian, et al.European Journal of Pharmacology|January 4, 2005
Potential role of c-Jun NH2-terminal kinase in allergic airway inflammation and remodelling: effects of SP600125Puneeta Nath, Paul Eynott, Sum-Yee Leung, et al.British Journal of Pharmacology|November 19, 2003
Allergen-induced inflammation and airway epithelial and smooth muscle cell proliferation: role of Jun N-terminal kinasePaul R Eynott, Puneeta Nath, Sum-Yee Leung, et al.Pageof 3